For citations:
Kobalava J.D., Gurevich V.S., Galyavich A.M., Kaminnyi A.I., Kashtalap V.V., Mareev V.Yu., Susekov A.V., Shaposhnik I.I. Possibilities of clinical use of ezetimibe Otrio (JSC “AKRIKHIN”, Russia) in patients with high and very high cardiovascular risk who have not reached the target values of lipid metabolism. Conclusion of the Board of experts. Kardiologiia. 2019;59(5S):47-57. (In Russ.) https://doi.org/10.18087/cardio.n581
Email this article 
Post a Comment 
